This Eli Lilly Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday
Author: Avi Kapoor | August 27, 2025 01:49pm
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Scotiabank analyst Nicholas Yulico upgraded Prologis, Inc. (NYSE:PLD) from Sector Underperform to Sector Perform and raised the price target from $100 to $114. Prologis shares closed at $111.35 on Tuesday. See how other analysts view this stock.
HSBC analyst Akshay Gupta upgraded the rating for Amer Sports, Inc. (NYSE:AS) from Hold to Buy and boosted the price target from $38 to $50. Amer Sports shares closed at $40.71 on Tuesday. See how other analysts view this stock.
HSBC analyst Rajesh Kumar upgraded Eli Lilly and Company (NYSE:LLY) from Reduce to Hold and raised the price target from $675 to $700. Eli Lilly shares closed at $736.03 on Tuesday. See how other analysts view this stock.
B of A Securities analyst Geoff Meacham upgraded Vir Biotechnology, Inc. (NASDAQ:VIR) from Neutral to Buy and raised the price target from $12 to $14. Vir Biotechnology shares closed at $4.44 on Tuesday. See how other analysts view this stock.
Considering buying LLY stock? Here’s what analysts think:
